Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
17 hedge funds and large institutions have $508K invested in Biocept, Inc. in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
78% more capital invested
Capital invested by funds: $285K → $508K (+$222K)
31% more funds holding
Funds holding: 13 → 17 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$95.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83K |
| 3 |
Barclays
London,
United Kingdom
|
+$40.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$29.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$63.2K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$49K |
| 3 |
Renaissance Technologies
New York
|
-$38K |
| 4 |
Jane Street
New York
|
-$11K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$7K |
BIOC Hedge Fund Activity: Q1 2019 in Review
17 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2019, worth a combined $508K — up 78% from $285K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BIOC positions and 5 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $95.2K. The largest seller was Dimensional Fund Advisors, cutting an estimated $63.2K.
- 17 institutional investors held Biocept, Inc. (BIOC) as of Q1 2019, up from 13 in Q4 2018.
- Funds reported $508K of Biocept, Inc. stock for Q1 2019, up 78% quarter-over-quarter.
- 9 funds opened new Biocept, Inc. positions in Q1 2019 and 5 closed out, a net change of +4 holders.
- The largest Biocept, Inc. buyer in Q1 2019 was Geode Capital Management, an estimated $95.2K added.
- The largest Biocept, Inc. seller in Q1 2019 was Dimensional Fund Advisors, an estimated $63.2K sold.
Based on aggregated 13F filings for Q1 2019.